Germany’s chemical industry trade association, the VCI, said that the mood in the nation’s chemical and pharmaceutical industry “cooled noticeably in August because the global economy did not pick up as hoped”. This applies particularly to chemicals. “A weak industrial economy in Europe, the USA and China, as well as a lack of price-competitiveness in Germany, are dampening sales opportunities abroad,” the VCI said.

CDMO and API manufacturer Seqens has announced a “multi-million dollar” investment in its R&D laboratory in Devens, Massachusetts, which is due to be completed in October. The firm said that this will ensure that the new facility can operate at the highest standards of safety and quality.